Subscribe to RSS
DOI: 10.1055/s-0044-1778701
MVP-Assisted Temporary Vascular Occlusion during 90Y Radioembolization: A Case Report
Funding J.J.P. is a proctor for Sirtex Medical, Inc., and medical advisory board member for Boston Scientific.F.E.B. is a co-founder of Claripacs, LLC. He received research grants from Guerbet, Society of Interventional Oncology, Department of Defense, Thompson Family Foundation, Brockman Medical Research Foundation, and City of Hope. He received research support (investigator-initiated) from GE Healthcare. He received research supplies (investigator-initiated) from Boston Scientific. He is an investor in Labdoor, Qventus, CloudMedx, Notable Labs, Xgenomes, and Solugen. He is the inventor and assignee on U.S. patent 8233586.
Abstract
Yttrium-90 radioembolization is an effective treatment for liver cancers. However, deposition of radioactive microspheres in nondiseased liver can result in parenchymal injury. Segmental and subsegmental radioembolization may reduce off-target liver damage but may not always be possible due to anatomy. In this case report, we highlight the use of a microvascular plug (MVP) to protect distal nondiseased liver and redirect flow into the proximal tumor-containing liver volume during radioembolization of a gallbladder cancer recurrence. Throughout the report, we describe the technique, advantages, and limitations of using MVP-assisted temporary vascular occlusion during organ protection.
Publication History
Article published online:
29 January 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Reincke M, Schultheiss M, Doppler M. et al. Hepatic decompensation after transarterial radioembolization: a retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma. Hepatol Commun 2022; 6 (11) 3223-3233
- 2 Pedersoli F, Boas FE, Park JJ. Temporary vascular occlusion with retrievable microvascular plugs to protect normal liver during yttrium-90 radioembolization. J Vasc Interv Radiol 2023; 34 (06) 978-982
- 3 Core JM, Frey GT, Sharma A. et al. Increasing yttrium-90 dose conformality using proximal radioembolization enabled by distal angiosomal truncation for the treatment of hepatic malignancy. J Vasc Interv Radiol 2020; 31 (06) 934-942
- 4 Meyer C, Pieper CC, Ezziddin S, Wilhelm KE, Schild HH, Ahmadzadehfar H. Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours. Eur J Nucl Med Mol Imaging 2014; 41 (02) 231-237